3.40p-0.05 (-1.45%)20 May 2022, 16:15
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Omega Diagnostics Group PLC Fundamentals

Company NameOmega Diagnostics Group PLCLast Updated2022-05-20
IndustryMedical Instruments & SuppliesSectorHealthcare
Shares in Issue232.682 mMarket Cap£7.91 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.01EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0918Debt Equity Ratio0.1117
Asset Equity Ratio1.4045Cash Equity Ratio0.2283
Quick Ratio1.5640Current Ratio2.04
Price To Book Value0.3845ROCE0

Omega Diagnostics Group PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Omega Diagnostics Group PLC Company Financials

Tangible Assets£4.88 m£3.16 m£1.57 m
Intangible Assets£10.18 m£9.68 m£17.04 m
Total Fixed Assets£18.75 m£14.38 m£19.99 m
Stocks£2.24 m£1.17 m£1.00 m
Debtors£4.04 m£3.19 m£2.31 m
Cash & Equivalents£5.83 m00
Other Assets000
Total Assets£30.99 m£18.84 m£23.48 m
Creditors within 1 year£3.55 m£2.34 m£2.31 m
Creditors after 1 year£3.76 m£2.89 m£2.98 m
Other Liabilities000
Total Liabilities£7.32 m£5.23 m£5.28 m
Net assets£23.67 m£13.61 m£18.19 m
Called up share capital£33.32 m£22.01 m£19.80 m
Share Premium000
Profit / Loss-£3.54 m-£8.30 m-£368,417.00
Other Equity£23.67 m£13.61 m£18.19 m
Preference & Minorities000
Total Capital Employed£23.67 m£13.61 m£18.19 m
Debt Ratio£0.09£0.12£0.00
Assets / Equity1.40451.40451.4045
Cash / Equity0.22830.22830.2283
Cash Flow202120202019
Cash from operating activities-£2.42 m£547,607.00£368,819.00
Cashflow before financing£8.65 m£2.18 m£903,789.00
Increase in Cash£5.83 m£29,814.00£9,324.00
Turnover£8.73 m£9.82 m£8.76 m
Cost of sales£4.28 m£3.52 m£3.12 m
Gross Profit£4.46 m£6.29 m£5.63 m
Operating Profit00-£271,343.00
Pre-Tax profit-£3.54 m-£8.30 m-£368,417.00

Omega Diagnostics Group PLC Company Background

ActivitiesOmega Diagnostics Group PLC provides in-vitro diagnostics (IVD) products for use in hospitals, blood banks, clinics and laboratories and specializes in the areas of allergy and autoimmune, food intolerance and infectious diseases. The company's segment includes Health and Nutrition; Global Health and Other. It generates maximum revenue from the Health and Nutrition segment. The Health and Nutrition division specialises in the research, development, and production of kits to aid the detection of immune reactions to food. Geographically, it derives a majority of revenue from Asia and the Far East region.
Latest Interim Date25 Nov 2021
Latest Fiscal Year End Date13 Jul 2021

Omega Diagnostics Group PLC Directors

2012-07-11Mr. Geoff GowerExecutive Director
2021-07-13Mr. Kieron Antony HarbinsonExecutive Director,Finance Director and Company Secretary
2013-07-01Mr. Michael Stephen GurnerNon-Executive Director
2019-10-01Mr. David Eric EvansNon-Executive Director,Chairman
2018-08-15Mr. Andrew William ShepherdExecutive Director,Chief Executive Officer
2008-06-05Dr. Michael Strachan Walker, B.Sc. ,PhDNon-Executive Director
2021-07-30Mr. Jagdeep GrewalExecutive Director,Chief Executive Officer
2022-01-19Mr. William E. Rhodes IIINon-Executive Director
2021-07-30Mr. Jeremy Howard Millard Non-Executive Director
2022-01-19Mr. Colin KingExecutive Director,Chief Executive Officer
2021-07-30Dr. Simon Gordon Douglas Non-Executive Director,Chairman

Omega Diagnostics Group PLC Contact Details

Company NameOmega Diagnostics Group PLC
AddressOne Fleet Place, London, EC4M 7WS
Telephone+44 1259763030

Omega Diagnostics Group PLC Advisors

BankNational Westminster Bank PLC
Phone+44 2072200500
Fax+44 2076001659
Financial PR AdviserWalbrook PR
Phone+44 2079338780
Fax+44 2079338781
RegistrarShare Registrars Limited
Phone+44 1252821390
Fax+44 1252719232
SolicitorBrodies LLP
Phone(0131) 228 3777
Fax(0131) 228 3878
Nominated AdviserFinnCap
Phone+44 2072200500
Fax+44 2076001659